Consistent with our results obtained from the DNA methylation analysis, high PD-L2 mRNA expression appears to be correlated with patients’ prolonged progression-free survival in metastatic melanoma patients under anti-PD-1 therapy provided by Liu et al. [25]. The gene discussed is PDCD1; the disease is metastatic melanoma.